These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33946749)

  • 1. Universal Detection of Mi
    Yang MH; Chen JW; Sayaka K; Uchikawa M; Tsuno NH; Wei ST; Hou SM; Chen YJ
    Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33946749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi
    Yang CA; Lin JA; Chang CW; Wu KH; Yeh SP; Ho CM; Chang JG
    Transfus Med; 2016 Oct; 26(5):349-354. PubMed ID: 27634577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequencies of glycophorin variants and alloantibodies against Hil and MINY antigens in Japanese.
    Kaito S; Suzuki Y; Masuno A; Isa K; Toyoda C; Onodera T; Ogasawara K; Uchikawa M; Tsuno NH; Satake M
    Vox Sang; 2022 Jan; 117(1):94-98. PubMed ID: 34227688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid glycophorin and red blood cell antigen genotyping in Asian American type O blood donors with Mi
    Lin X; Rubio G; Patel J; Banerjee S; Frame T; Billups N; Yang J
    Transfusion; 2019 Dec; 59(12):3767-3775. PubMed ID: 31697429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto red blood cells.
    Heathcote D; Carroll T; Wang JJ; Flower R; Rodionov I; Tuzikov A; Bovin N; Henry S
    Transfusion; 2010 Mar; 50(3):635-41. PubMed ID: 19912581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A direct blood polymerase chain reaction approach for the determination of GP.Mur (Mi.III) and other Hil+ Miltenberger glycophorin variants.
    Hsu K; Lin YC; Chang YC; Chan YS; Chao HP; Lee TY; Lin M
    Transfusion; 2013 May; 53(5):962-71. PubMed ID: 22924868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of GYP*Mur and novel GYP*Bun-like hybrids in Thai blood donors reveals a qualitatively altered s antigen.
    Jongruamklang P; Grimsley S; Thornton N; Robb J; Olsson ML; Storry JR
    Vox Sang; 2020 Jul; 115(5):472-477. PubMed ID: 32201961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the antigens and antibodies of Mur and Mi
    Li Q; Duan S; Sun A; Liao Y; Wu Y; Wang H; Lin H; Huang X; Zhan Z
    Transfus Apher Sci; 2022 Aug; 61(4):103378. PubMed ID: 35216928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence, immunogenicity, and evanescence of alloantibodies to MUT and Mur antigens of GP.Mur red blood cells in a Southeast Asian patient cohort.
    Nadarajan VS
    Transfusion; 2018 May; 58(5):1189-1198. PubMed ID: 29441590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic analysis of Mi
    Wei L; Sun A; Wen J; Wang Z; Li Q; Liao Y; Luo G; Ji Y
    Transfusion; 2021 Aug; 61(8):2477-2486. PubMed ID: 34117642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Mi
    Lopez GH; Wilson B; Turner RM; Millard GM; Fraser NS; Roots NM; Liew YW; Hyland CA; Flower RL
    Transfus Med Hemother; 2020 Jul; 47(4):279-286. PubMed ID: 32884500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GP.MOT: A novel glycophorin variant identified in a Japanese blood donor.
    Oda A; Suzuki Y; Isa K; Ogasawara K; Yabe R; Kimura T; Uchikawa M; Tsuno NH
    Transfusion; 2021 Oct; 61(10):2825-2829. PubMed ID: 34369596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of GP Mur and anti-"Mia" in a tertiary hospital in Peninsula Malaysia.
    Prathiba R; Lopez CG; Usin FM
    Malays J Pathol; 2002 Dec; 24(2):95-8. PubMed ID: 12887167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of MNS hybrid glycophorins with Mur antigen expression in Chinese donors including identification of a novel GYP.Bun allele.
    Wei L; Shan ZG; Flower RL; Wang Z; Wen JZ; Luo GP; Ji YL
    Vox Sang; 2016 Oct; 111(3):308-314. PubMed ID: 27232276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful prenatal management of two foetuses affected by antibodies against GP.Mur with prenatal genotyping analysis and a literature review.
    Li S; Wei L; Fang Q; Ji Y; Lin L; Gao Y
    Blood Transfus; 2021 Mar; 19(2):135-143. PubMed ID: 33085590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MNS glycophorin variant GP.Mur affects differential erythroid expression of Rh/RhAG transcripts.
    Hsu K; Kuo MS; Yao CC; Cheng HC; Lin HJ; Chan YS; Lin M
    Vox Sang; 2017 Oct; 112(7):671-677. PubMed ID: 28836328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MNSs blood group glycophorin variants in Taiwan: a genotype-serotype correlation study of 'Mi(a)' and St(a) with report of two new alleles for St(a).
    Chen TD; Chen DP; Wang WT; Sun CF
    PLoS One; 2014; 9(5):e98166. PubMed ID: 24858913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miltenberger blood group typing by real-time polymerase chain reaction (qPCR) melting curve analysis in Thai population.
    Vongsakulyanon A; Kitpoka P; Kunakorn M; Srikhirin T
    Transfus Med; 2015 Dec; 25(6):393-8. PubMed ID: 26681402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorimetric Detection by Gold Nanoparticle DNA Probes for Miltenberger Series (GP.Mur, GP.Hop, and GP.Bun) Identification.
    Vongsakulyanon A; Pipatpanukul C; Kitpoka P; Kunakorn M; Srikhirin T
    J Clin Lab Anal; 2016 Nov; 30(6):880-887. PubMed ID: 27075240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic disease of the fetus and newborn caused by anti-s
    Lopez GH; Emthip M; Suwanwootichai P; Millard GM; Wilson B; Onpuns S; Laemsri K; Chiewsilp P; Flower RL; Hyland CA; Liew YW
    Transfusion; 2022 Oct; 62(10):2137-2142. PubMed ID: 36062546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.